Ultra-small, low-power devices create a platform to empower the future of bioelectronic medicine and transform how the world monitors and treats disease.
iota holds exclusive license to millimeter-sized, ultrasonic-powered bioelectronic devices developed at UC Berkeley. Also known as “neural dust” because of their small size and ability to interface directly with the central nervous system, these battery-free implantable devices enable doctors to safely get closer than ever to the internal causes of disease.
Neural Dust Platform
Powered by ultrasound: No batteries, no wires. These devices can record electrical information, stimulate nerves and communicate with other machines through ultrasound, a medium with a long safety track record.
Smaller than a grain of sand: Iota’s devices are just a few millimeters long, so they can be implanted practically anywhere in the body. Future implants could scale down to less than one cubic millimeter.
Reads and writes nerve activity: Neural dust devices can modulate the information transmitted through nerves, enabling doctors to better treat conditions from arthritis to cardiovascular disease.
Neural dust can be implanted practically anywhere in the body to gather precise data or to directly stimulate nerves. We envision a world in which implantables are as common as pills and are used by doctors in conjunction with, or as an alternative to, traditional forms of therapy.